Kimball Electronics (KE) The Stifel 2024 Cross Sector Insight Conference summary
Event summary combining transcript, slides, and related documents.
The Stifel 2024 Cross Sector Insight Conference summary
31 Jan, 2026Business Overview and Strategy
Focuses on automotive, medical, and industrial verticals, emphasizing high-complexity, non-commodity products and selective program participation with a 75% win rate in targeted bids.
Global operations span North America, Europe, and Asia, with 14 manufacturing facilities and over 7,900 employees worldwide.
Customer relationships are long-term, with 77% of revenue from customers over 10 years, supporting multi-year planning and operating efficiency.
The company is divesting its Automation, Test & Measurement business to concentrate on core EMS operations and has realigned its medical solutions into the EMS vertical.
Capital allocation prioritizes organic growth, customer relationships, share repurchases, and disciplined M&A.
Financial Performance and Guidance
Fiscal 2023 revenue reached $1.823 billion, up 35% year-over-year, with a five-year CAGR of 11%.
Adjusted operating income margin improved by 110 basis points to 4.8%, and ROIC rose to 9.4%.
Fiscal 2024 guidance: adjusted operating income margin of 4.2% to 4.6% of net sales; net sales expected to decline 4% to 6% versus 2023.
Capital expenditures for fiscal 2024 are expected at $55–$60 million, down from a previous estimate of $70–$80 million.
Additional pre-tax restructuring charges of $1–$2 million are anticipated as the company continues streamlining.
Market Conditions and Growth Drivers
EMS industry faces short-term demand softening and supply chain inventory excess, with headwinds expected to persist into fiscal 2025.
Automotive segment, driven by vehicle electrification, represents 45% of revenue and grew 41% in fiscal 2023.
Medical segment, focused on patient monitoring and connected care, accounts for 27% of revenue and grew 26%.
Industrial segment, supporting clean energy and automation, makes up 26% of revenue and grew 33%.
Growth in automotive is driven by electronification, such as ADAS and enhanced braking/steering features, with programs typically single-source and lasting 8–10 years.
Latest events from Kimball Electronics
- Q4 growth and margin gains set up a 7–9% FY27 outlook, driven by medical and Helvoet.KE
Q4 2026 - Medical segment growth and new facility drive raised outlook and margin expansion plans.KE
2026 KeyBanc Capital Markets Healthcare Forum - Acquisition expands global medical CMO platform, boosting growth and earnings by 2027.KE
M&A announcement - Profitable growth expected as medical and automotive markets drive margin expansion and investment.KE
Company presentation - Medical-led sequential growth and strong margins support high-end fiscal 2026 outlook.KE
Q3 2026 - Raised FY26 guidance and expanded medical focus drive profitable growth outlook.KE
Company presentation - Q2 sales fell 5% but margins and 2026 guidance improved on strong medical growth.KE
Q2 2026 - Q1 FY2025 sales fell 15% as restructuring and asset sales improved cash flow and reduced debt.KE
Q1 2025 - Q4 sales dropped 13% as inventory and liquidity improved; 2025 outlook remains cautious.KE
Q4 2024